FDA Cites Emcure For Validation, Testing and Reporting Issues

Drug Industry Daily
A A
The FDA flagged API manufacturer Emcure Pharmaceuticals, citing inadequate validation, testing and reporting.

To View This Article:

Login

Subscribe To Drug Industry Daily